# LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs)

> **NCT01188928** · PHASE3 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 1152 (actual)

## Conditions studied

- Psoriasis Vulgaris

## Interventions

- **DRUG:** Calcipotriol plus betamethasone
- **DRUG:** Betamethasone-17,21-dipropionate
- **DRUG:** Calcipotriene
- **DRUG:** Topical suspension vehicle

## Key facts

- **NCT ID:** NCT01188928
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 1152 (ACTUAL)
- **Last updated:** 2025-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01188928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01188928, "LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01188928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*